Bleomycin - 61703-323-22 - (BLEOMYCIN SULFATE)

Alphabetical Index


Drug Information of Bleomycin

Product NDC: 61703-323
Proprietary Name: Bleomycin
Non Proprietary Name: BLEOMYCIN SULFATE
Active Ingredient(s): 30    [USP'U]/1 & nbsp;   BLEOMYCIN SULFATE
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Bleomycin

Product NDC: 61703-323
Labeler Name: Hospira Worldwide, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA065031
Marketing Category: ANDA
Start Marketing Date: 20000310

Package Information of Bleomycin

Package NDC: 61703-323-22
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-323-22) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

NDC Information of Bleomycin

NDC Code 61703-323-22
Proprietary Name Bleomycin
Package Description 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-323-22) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
Product NDC 61703-323
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name BLEOMYCIN SULFATE
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 20000310
Marketing Category Name ANDA
Labeler Name Hospira Worldwide, Inc.
Substance Name BLEOMYCIN SULFATE
Strength Number 30
Strength Unit [USP'U]/1
Pharmaceutical Classes Cytoprotective Agent [EPC]

Complete Information of Bleomycin


General Information